Comprehensive information about experimentally validated enhancers
| Enhancer ID: | E_01244 |
| Species: | Homo sapiens |
| Position : | chr11:70030000-70079999 |
| Year: | 2020 |
| Title: | Gene duplication, rather than epigenetic changes, drives FGF4 overexpression in KIT/PDGFRA/SDH/RAS-P WT GIST |
| Genome Build: | hg19 |
| Enhancer Type: | Enhancer |
| Condition: | Disease |
| Disease Name: | gastrointestinal stromal tumor |
| PMID: | 33199729 |
| MONDO: | MONDO:0005047 |
| Tissue: | Small intestine |
| Tissue Ontology ID: | UBERON:0002108 |
| Cell Source: | KIT mutant GIST) |
| CVCL ID: | |
| Cell Type: | gastrointestinal stromal tumor cell |
| Cell Ontology ID: | CL:0000066 |
| Experiment Type: | Chromatin interaction assay, Enhancer activity assay |
| High Throughput Method: | RNA-seq, ChIP-seq |
| Low Throughput Method: | Sanger sequencing, bisulfite sequencing, RT-qPCR |
| Target gene : | FGF4 |
| TF name : |
| Regulatory State : | Active |
| GeneName | Pathway Name | Source | Gene Number |
|---|